Urea and carbamate derivatives of primaquine: Synthesis, cytostatic and antioxidant activities

We describe novel urea and carbamate derivatives of primaquine, and their cytostatic and antioxidant activities. 1-(5-Hydroxypentyl)-3-[4-(6-methoxy-quinolin-8-ylamino)-pentyl]-urea ( 3c) shows extreme selectivity toward SW 620 colon cancer cells. The novel urea primaquine derivatives 3 were prepare...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2009-08, Vol.17 (15), p.5605-5613
Hauptverfasser: Šimunović, M., Perković, I., Zorc, B., Ester, K., Kralj, M., Hadjipavlou-Litina, D., Pontiki, E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5613
container_issue 15
container_start_page 5605
container_title Bioorganic & medicinal chemistry
container_volume 17
creator Šimunović, M.
Perković, I.
Zorc, B.
Ester, K.
Kralj, M.
Hadjipavlou-Litina, D.
Pontiki, E.
description We describe novel urea and carbamate derivatives of primaquine, and their cytostatic and antioxidant activities. 1-(5-Hydroxypentyl)-3-[4-(6-methoxy-quinolin-8-ylamino)-pentyl]-urea ( 3c) shows extreme selectivity toward SW 620 colon cancer cells. The novel urea primaquine derivatives 3 were prepared by aminolysis of primaquine benzotriazolide 2 with several hydroxyamines and ethylendiamine, while carbamates 4 were synthesized from the same precursor 2 and alcohols. All compounds are fully chemically characterized and evaluated for their cytostatic and antioxidant activities. The most prominent antiproliferative activity was obtained by compounds 3c, 3d, 3g, and 5b (IC 50 = 9–40 μM). 1-(5-Hydroxypentyl)-3-[4-(6-methoxy-quinolin-8-ylamino)-pentyl]urea ( 3c) showed extreme selectivity toward SW 620 colon cancer cells (IC 50 = 0.2 μM) and a bit less toward lung cancer cells H 460. Hydroxyurea 3h showed the highest interaction with DPPH. Primaquine twin drug 3g showed very significant inhibition on LOX soybean (IC 50 = 62 μM). Almost all the tested derivatives highly inhibited lipid peroxidation, significantly stronger than primaquine phosphate.
doi_str_mv 10.1016/j.bmc.2009.06.030
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20708041</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089609005847</els_id><sourcerecordid>20708041</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-dd2dd802313454a69d9fc7d4e7d8c9c6cb92ee59553385a87e9135769e67f4103</originalsourceid><addsrcrecordid>eNp9kMtuFDEQRS0EIpPAB7BBvYFVuik_2m2TFYp4SZFYQLZYnnK18Gi6O7E9I-bvcTIj2LG6m3Ovqg5jrzh0HLh-t-nWE3YCwHagO5DwhK240qqV0vKnbAVWmxaM1WfsPOcNAAhl-XN2xm1vOFizYj9vE_nGz6FBn9Z-8oWaQCnufYl7ys0yNncpTv5-F2d633w_zOUX5ZgvGzyUJZeK4WPdzyUuv2Oo2Xis5Vgi5Rfs2ei3mV6e8oLdfvr44_pLe_Pt89frDzctKi5KG4IIwYCQXKpeeW2DHXEIioZg0KLGtRVEve17KU3vzUCWy37QlvQwKg7ygr097t6l5X5HubgpZqTt1s-07LITMIABxSvIjyCmJedEo3t8Lx0cB_cg1W1cleoepDrQrkqtnden8d16ovCvcbJYgTcnwGf02zH5GWP-ywk-WBDQV-7qyFFVsY-UXMZIM1KIibC4sMT_nPEHI-iVGg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20708041</pqid></control><display><type>article</type><title>Urea and carbamate derivatives of primaquine: Synthesis, cytostatic and antioxidant activities</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Šimunović, M. ; Perković, I. ; Zorc, B. ; Ester, K. ; Kralj, M. ; Hadjipavlou-Litina, D. ; Pontiki, E.</creator><creatorcontrib>Šimunović, M. ; Perković, I. ; Zorc, B. ; Ester, K. ; Kralj, M. ; Hadjipavlou-Litina, D. ; Pontiki, E.</creatorcontrib><description>We describe novel urea and carbamate derivatives of primaquine, and their cytostatic and antioxidant activities. 1-(5-Hydroxypentyl)-3-[4-(6-methoxy-quinolin-8-ylamino)-pentyl]-urea ( 3c) shows extreme selectivity toward SW 620 colon cancer cells. The novel urea primaquine derivatives 3 were prepared by aminolysis of primaquine benzotriazolide 2 with several hydroxyamines and ethylendiamine, while carbamates 4 were synthesized from the same precursor 2 and alcohols. All compounds are fully chemically characterized and evaluated for their cytostatic and antioxidant activities. The most prominent antiproliferative activity was obtained by compounds 3c, 3d, 3g, and 5b (IC 50 = 9–40 μM). 1-(5-Hydroxypentyl)-3-[4-(6-methoxy-quinolin-8-ylamino)-pentyl]urea ( 3c) showed extreme selectivity toward SW 620 colon cancer cells (IC 50 = 0.2 μM) and a bit less toward lung cancer cells H 460. Hydroxyurea 3h showed the highest interaction with DPPH. Primaquine twin drug 3g showed very significant inhibition on LOX soybean (IC 50 = 62 μM). Almost all the tested derivatives highly inhibited lipid peroxidation, significantly stronger than primaquine phosphate.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2009.06.030</identifier><identifier>PMID: 19581098</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antimalarials - chemical synthesis ; Antimalarials - chemistry ; Antimalarials - pharmacology ; Antineoplastic agents ; Antioxidants - chemical synthesis ; Antioxidants - chemistry ; Antioxidants - pharmacology ; Antiparasitic agents ; Biological and medical sciences ; Biphenyl Compounds - metabolism ; Carbamate ; Carbamates - chemical synthesis ; Carbamates - chemistry ; Carbamates - pharmacology ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Cytostatic activity ; Cytostatic Agents - chemical synthesis ; Cytostatic Agents - chemistry ; Cytostatic Agents - pharmacology ; General aspects ; Glycine max - enzymology ; Humans ; Lipid peroxidation ; Lipid Peroxidation - drug effects ; Lipoxygenase - metabolism ; Medical sciences ; Molecular Structure ; Pharmacology. Drug treatments ; Picrates - metabolism ; Primaquine ; Primaquine - chemical synthesis ; Primaquine - chemistry ; Primaquine - pharmacology ; Soybean lipoxygenase ; Urea ; Urea - analogs &amp; derivatives ; Urea - chemical synthesis ; Urea - pharmacology</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2009-08, Vol.17 (15), p.5605-5613</ispartof><rights>2009 Elsevier Ltd</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-dd2dd802313454a69d9fc7d4e7d8c9c6cb92ee59553385a87e9135769e67f4103</citedby><cites>FETCH-LOGICAL-c412t-dd2dd802313454a69d9fc7d4e7d8c9c6cb92ee59553385a87e9135769e67f4103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmc.2009.06.030$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21790205$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19581098$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Šimunović, M.</creatorcontrib><creatorcontrib>Perković, I.</creatorcontrib><creatorcontrib>Zorc, B.</creatorcontrib><creatorcontrib>Ester, K.</creatorcontrib><creatorcontrib>Kralj, M.</creatorcontrib><creatorcontrib>Hadjipavlou-Litina, D.</creatorcontrib><creatorcontrib>Pontiki, E.</creatorcontrib><title>Urea and carbamate derivatives of primaquine: Synthesis, cytostatic and antioxidant activities</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>We describe novel urea and carbamate derivatives of primaquine, and their cytostatic and antioxidant activities. 1-(5-Hydroxypentyl)-3-[4-(6-methoxy-quinolin-8-ylamino)-pentyl]-urea ( 3c) shows extreme selectivity toward SW 620 colon cancer cells. The novel urea primaquine derivatives 3 were prepared by aminolysis of primaquine benzotriazolide 2 with several hydroxyamines and ethylendiamine, while carbamates 4 were synthesized from the same precursor 2 and alcohols. All compounds are fully chemically characterized and evaluated for their cytostatic and antioxidant activities. The most prominent antiproliferative activity was obtained by compounds 3c, 3d, 3g, and 5b (IC 50 = 9–40 μM). 1-(5-Hydroxypentyl)-3-[4-(6-methoxy-quinolin-8-ylamino)-pentyl]urea ( 3c) showed extreme selectivity toward SW 620 colon cancer cells (IC 50 = 0.2 μM) and a bit less toward lung cancer cells H 460. Hydroxyurea 3h showed the highest interaction with DPPH. Primaquine twin drug 3g showed very significant inhibition on LOX soybean (IC 50 = 62 μM). Almost all the tested derivatives highly inhibited lipid peroxidation, significantly stronger than primaquine phosphate.</description><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antimalarials - chemical synthesis</subject><subject>Antimalarials - chemistry</subject><subject>Antimalarials - pharmacology</subject><subject>Antineoplastic agents</subject><subject>Antioxidants - chemical synthesis</subject><subject>Antioxidants - chemistry</subject><subject>Antioxidants - pharmacology</subject><subject>Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Biphenyl Compounds - metabolism</subject><subject>Carbamate</subject><subject>Carbamates - chemical synthesis</subject><subject>Carbamates - chemistry</subject><subject>Carbamates - pharmacology</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Cytostatic activity</subject><subject>Cytostatic Agents - chemical synthesis</subject><subject>Cytostatic Agents - chemistry</subject><subject>Cytostatic Agents - pharmacology</subject><subject>General aspects</subject><subject>Glycine max - enzymology</subject><subject>Humans</subject><subject>Lipid peroxidation</subject><subject>Lipid Peroxidation - drug effects</subject><subject>Lipoxygenase - metabolism</subject><subject>Medical sciences</subject><subject>Molecular Structure</subject><subject>Pharmacology. Drug treatments</subject><subject>Picrates - metabolism</subject><subject>Primaquine</subject><subject>Primaquine - chemical synthesis</subject><subject>Primaquine - chemistry</subject><subject>Primaquine - pharmacology</subject><subject>Soybean lipoxygenase</subject><subject>Urea</subject><subject>Urea - analogs &amp; derivatives</subject><subject>Urea - chemical synthesis</subject><subject>Urea - pharmacology</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtuFDEQRS0EIpPAB7BBvYFVuik_2m2TFYp4SZFYQLZYnnK18Gi6O7E9I-bvcTIj2LG6m3Ovqg5jrzh0HLh-t-nWE3YCwHagO5DwhK240qqV0vKnbAVWmxaM1WfsPOcNAAhl-XN2xm1vOFizYj9vE_nGz6FBn9Z-8oWaQCnufYl7ys0yNncpTv5-F2d633w_zOUX5ZgvGzyUJZeK4WPdzyUuv2Oo2Xis5Vgi5Rfs2ei3mV6e8oLdfvr44_pLe_Pt89frDzctKi5KG4IIwYCQXKpeeW2DHXEIioZg0KLGtRVEve17KU3vzUCWy37QlvQwKg7ygr097t6l5X5HubgpZqTt1s-07LITMIABxSvIjyCmJedEo3t8Lx0cB_cg1W1cleoepDrQrkqtnden8d16ovCvcbJYgTcnwGf02zH5GWP-ywk-WBDQV-7qyFFVsY-UXMZIM1KIibC4sMT_nPEHI-iVGg</recordid><startdate>20090801</startdate><enddate>20090801</enddate><creator>Šimunović, M.</creator><creator>Perković, I.</creator><creator>Zorc, B.</creator><creator>Ester, K.</creator><creator>Kralj, M.</creator><creator>Hadjipavlou-Litina, D.</creator><creator>Pontiki, E.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20090801</creationdate><title>Urea and carbamate derivatives of primaquine: Synthesis, cytostatic and antioxidant activities</title><author>Šimunović, M. ; Perković, I. ; Zorc, B. ; Ester, K. ; Kralj, M. ; Hadjipavlou-Litina, D. ; Pontiki, E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-dd2dd802313454a69d9fc7d4e7d8c9c6cb92ee59553385a87e9135769e67f4103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antimalarials - chemical synthesis</topic><topic>Antimalarials - chemistry</topic><topic>Antimalarials - pharmacology</topic><topic>Antineoplastic agents</topic><topic>Antioxidants - chemical synthesis</topic><topic>Antioxidants - chemistry</topic><topic>Antioxidants - pharmacology</topic><topic>Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Biphenyl Compounds - metabolism</topic><topic>Carbamate</topic><topic>Carbamates - chemical synthesis</topic><topic>Carbamates - chemistry</topic><topic>Carbamates - pharmacology</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Cytostatic activity</topic><topic>Cytostatic Agents - chemical synthesis</topic><topic>Cytostatic Agents - chemistry</topic><topic>Cytostatic Agents - pharmacology</topic><topic>General aspects</topic><topic>Glycine max - enzymology</topic><topic>Humans</topic><topic>Lipid peroxidation</topic><topic>Lipid Peroxidation - drug effects</topic><topic>Lipoxygenase - metabolism</topic><topic>Medical sciences</topic><topic>Molecular Structure</topic><topic>Pharmacology. Drug treatments</topic><topic>Picrates - metabolism</topic><topic>Primaquine</topic><topic>Primaquine - chemical synthesis</topic><topic>Primaquine - chemistry</topic><topic>Primaquine - pharmacology</topic><topic>Soybean lipoxygenase</topic><topic>Urea</topic><topic>Urea - analogs &amp; derivatives</topic><topic>Urea - chemical synthesis</topic><topic>Urea - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Šimunović, M.</creatorcontrib><creatorcontrib>Perković, I.</creatorcontrib><creatorcontrib>Zorc, B.</creatorcontrib><creatorcontrib>Ester, K.</creatorcontrib><creatorcontrib>Kralj, M.</creatorcontrib><creatorcontrib>Hadjipavlou-Litina, D.</creatorcontrib><creatorcontrib>Pontiki, E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Šimunović, M.</au><au>Perković, I.</au><au>Zorc, B.</au><au>Ester, K.</au><au>Kralj, M.</au><au>Hadjipavlou-Litina, D.</au><au>Pontiki, E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Urea and carbamate derivatives of primaquine: Synthesis, cytostatic and antioxidant activities</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2009-08-01</date><risdate>2009</risdate><volume>17</volume><issue>15</issue><spage>5605</spage><epage>5613</epage><pages>5605-5613</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>We describe novel urea and carbamate derivatives of primaquine, and their cytostatic and antioxidant activities. 1-(5-Hydroxypentyl)-3-[4-(6-methoxy-quinolin-8-ylamino)-pentyl]-urea ( 3c) shows extreme selectivity toward SW 620 colon cancer cells. The novel urea primaquine derivatives 3 were prepared by aminolysis of primaquine benzotriazolide 2 with several hydroxyamines and ethylendiamine, while carbamates 4 were synthesized from the same precursor 2 and alcohols. All compounds are fully chemically characterized and evaluated for their cytostatic and antioxidant activities. The most prominent antiproliferative activity was obtained by compounds 3c, 3d, 3g, and 5b (IC 50 = 9–40 μM). 1-(5-Hydroxypentyl)-3-[4-(6-methoxy-quinolin-8-ylamino)-pentyl]urea ( 3c) showed extreme selectivity toward SW 620 colon cancer cells (IC 50 = 0.2 μM) and a bit less toward lung cancer cells H 460. Hydroxyurea 3h showed the highest interaction with DPPH. Primaquine twin drug 3g showed very significant inhibition on LOX soybean (IC 50 = 62 μM). Almost all the tested derivatives highly inhibited lipid peroxidation, significantly stronger than primaquine phosphate.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>19581098</pmid><doi>10.1016/j.bmc.2009.06.030</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0968-0896
ispartof Bioorganic & medicinal chemistry, 2009-08, Vol.17 (15), p.5605-5613
issn 0968-0896
1464-3391
language eng
recordid cdi_proquest_miscellaneous_20708041
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects Antibiotics. Antiinfectious agents. Antiparasitic agents
Antimalarials - chemical synthesis
Antimalarials - chemistry
Antimalarials - pharmacology
Antineoplastic agents
Antioxidants - chemical synthesis
Antioxidants - chemistry
Antioxidants - pharmacology
Antiparasitic agents
Biological and medical sciences
Biphenyl Compounds - metabolism
Carbamate
Carbamates - chemical synthesis
Carbamates - chemistry
Carbamates - pharmacology
Cell Line, Tumor
Cell Proliferation - drug effects
Cytostatic activity
Cytostatic Agents - chemical synthesis
Cytostatic Agents - chemistry
Cytostatic Agents - pharmacology
General aspects
Glycine max - enzymology
Humans
Lipid peroxidation
Lipid Peroxidation - drug effects
Lipoxygenase - metabolism
Medical sciences
Molecular Structure
Pharmacology. Drug treatments
Picrates - metabolism
Primaquine
Primaquine - chemical synthesis
Primaquine - chemistry
Primaquine - pharmacology
Soybean lipoxygenase
Urea
Urea - analogs & derivatives
Urea - chemical synthesis
Urea - pharmacology
title Urea and carbamate derivatives of primaquine: Synthesis, cytostatic and antioxidant activities
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T09%3A03%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Urea%20and%20carbamate%20derivatives%20of%20primaquine:%20Synthesis,%20cytostatic%20and%20antioxidant%20activities&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=%C5%A0imunovi%C4%87,%20M.&rft.date=2009-08-01&rft.volume=17&rft.issue=15&rft.spage=5605&rft.epage=5613&rft.pages=5605-5613&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2009.06.030&rft_dat=%3Cproquest_cross%3E20708041%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20708041&rft_id=info:pmid/19581098&rft_els_id=S0968089609005847&rfr_iscdi=true